Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02513121 · ClinicalTrials.gov registry record · NA

Dietary Treatment Study of Pediatric NAFLD

A NA study of Non-alcoholic Fatty Liver Disease, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT02513121: Completed NA study of Non-alcoholic Fatty Liver Disease, sponsored by University of California, San Diego.

NCT02513121 is a NA study of Non-alcoholic Fatty Liver Disease that has completed, run by University of California, San Diego. The registered enrollment target is 40 participants, below the 177-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02513121, a NA study of Non-alcoholic Fatty Liver Disease, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This is an investigator initiated study being conducted in equal numbers at two sites, University of California, San Diego (UC San Diego) and Emory University (EU). The purpose of this study is to understand the potential of a low sugar diet for the treatment of nonalcoholic fatty liver disease (NAFLD) in children. Forty boys with NAFLD will be randomly assigned to either an intervention group or a habitual diet control group. The intervention will be a low sugar diet for a period of 8 weeks. The effect of this dietary change will be assessed using advanced magnetic resonance imaging (MRI) testing to measure liver fat.

Primary Outcome

The principal objective of this randomized and controlled pilot study is to evaluate whether 8 weeks of a low added sugar diet (\<3%) in boys with NAFLD will change liver fat % measured by MRI.

Interventions

  • OTHER Dietary modification

Study Locations (2)

California

  • University of California, San Diego - San Diego

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-07
Est. Completion 2017-08-31
Phase NA
University of California, San Diego

775 total trials

What the finished NCT02513121 record still lists

NCT02513121 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 177-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Dietary modification is the first listed.

NCT02513121 reports a single indexed study location in California, Georgia.

Frequently Asked Questions

What is clinical trial NCT02513121 about?

NCT02513121 is a clinical study titled "Dietary Treatment Study of Pediatric NAFLD". This is an investigator initiated study being conducted in equal numbers at two sites, University of California, San Diego (UC San Diego) and Emory University (EU). The purpose of this study is to understand the potential of a low sugar diet for the treatment of nonalcoholic fatty liver disease (NAF...

What is the current status of trial NCT02513121?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-07. Estimated completion is 2017-08-31.

What conditions does trial NCT02513121 study?

This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.

What interventions are being tested in trial NCT02513121?

The interventions under investigation include: Dietary modification (OTHER).

Who is sponsoring clinical trial NCT02513121?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02513121 being conducted?

This trial has 2 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-alcoholic Fatty Liver Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02513121's enrollment target sits among peer trials

40 40th of 57 higher than 15 of 57 other Non-alcoholic Fatty Liver Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02513121, the US trial registry maintained by the National Library of Medicine. NCT02513121 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.